Zuo-Lin Li Selected Research

Zuo-Lin Li Research Topics

Disease

10	Inflammation (Inflammations) 05/2023 - 01/2018
9	Fibrosis (Cirrhosis) 05/2024 - 01/2019
9	Hypoxia (Hypoxemia) 01/2023 - 11/2019
8	Kidney Diseases (Kidney Disease) 12/2023 - 01/2018
8	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
6	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 01/2019
4	Ischemia 02/2024 - 11/2019
4	Neoplasms (Cancer) 01/2024 - 01/2022
4	Chronic Renal Insufficiency 03/2020 - 07/2019
3	Anemia 11/2020 - 11/2019
2	Genomic Instability 01/2024 - 01/2022
2	Reperfusion Injury 05/2022 - 01/2018
2	Ureteral Obstruction 10/2021 - 01/2021
2	Proteinuria 01/2020 - 01/2018
2	Albuminuria 01/2019 - 01/2018
2	IGA Glomerulonephritis (IGA Nephropathy) 11/2018 - 01/2018
1	Hypertension (High Blood Pressure) 05/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024
1	Carcinogenesis 01/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2022
1	Necrosis 01/2021
1	Iron Deficiencies 03/2020
1	Muscular Diseases (Myopathy) 11/2019
1	Secondary Hyperparathyroidism 07/2019
1	Hyperglycemia 01/2019
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2018

Drug/Important Bio-Agent (IBA)

4	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 06/2020
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2018
4	MicroRNAs (MicroRNA)IBA 12/2023 - 01/2020
4	Messenger RNA (mRNA)IBA 03/2022 - 01/2018
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2021
3	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 11/2022 - 03/2020
3	AlbuminsIBA 03/2022 - 01/2018
3	Prolyl-Hydroxylase InhibitorsIBA 11/2020 - 11/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2021
2	Sirtuin 1IBA 02/2024 - 01/2023
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 01/2019
2	TRPC6 Cation ChannelIBA 12/2022 - 06/2020
2	roxadustatIBA 05/2022 - 03/2020
2	Oxygen (Dioxygen)IBA 03/2022 - 01/2021
2	HematinicsIBA 11/2020 - 03/2020
2	InflammasomesIBA 07/2020 - 01/2018
2	N- (bis(4- methoxyphenyl)methyl)- 4- hydroxy- 2- (pyridazin- 3- yl)pyrimidine- 5- carboxamideIBA 11/2019 - 11/2019
1	AntigensIBA 05/2024
1	Angiotensin IIIBA 05/2024
1	VimentinIBA 05/2024
1	FumaratesIBA 02/2024
1	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2024
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2024
1	Environmental BiomarkersIBA 01/2024
1	Protein Kinases (Protein Kinase)IBA 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2024
1	QuercetinIBA 05/2023
1	HexokinaseIBA 01/2023
1	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2022
1	Long Noncoding RNAIBA 12/2022
1	Protein Isoforms (Isoforms)IBA 11/2022
1	ElectrolytesIBA 10/2022
1	Therapeutic UsesIBA 05/2022
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 05/2022
1	CreatinineIBA 03/2022
1	Peptides (Polypeptides)IBA 10/2021
1	A 68930IBA 07/2020
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 07/2020
1	Hemoglobins (Hemoglobin)IBA 03/2020
1	IronIBA 03/2020
1	HepcidinsIBA 03/2020
1	EnzymesIBA 03/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Parathyroid Hormone (Parathormone)IBA 07/2019
1	Cinacalcet (Sensipar)FDA Link 07/2019
1	GlucocorticoidsIBA 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2018
1	CathepsinsIBA 01/2018
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2018

Therapy/Procedure

7	Therapeutics 12/2023 - 01/2018
1	Immunotherapy 01/2024
1	Immunomodulation 01/2024
1	Nephrectomy 01/2020
1	Glycemic Control 01/2019